GENESIS Ventures

CORIFY Care is a start-up funded by main world-wide experts on cardiac arrhythmias which is going to introduce in the market a novel medical device to non-invasively map cardiac arrhythmias in real time. This novel technology will improve the treatment in more than 10 million of atrial fibrillation patients only in Europe. Our non-invasive electro-anatomical mapping systems displays the activation patterns in each point of the heart without the need of invasive catheters, allowing the possibility to map all atrial fibrillation patients even during a regular visit to the cardiologist. CORIFY Care is located in Madrid, Spain, one of the most attractive places to work/live on the South of Europe.

MOWOOT is a Non-pharmacological & Non-invasive solution for people suffering from chronic constipation. Its solution is a wearable medical device, which provides an automatic colon-specific massage similar to the manual abdominal massage administered by health professionals. MOWOOT utilizes advanced pneumatic technology to treat and prevent chronic slow transit constipation without colon cleansing supplements, enemas, and laxatives. The company emerged out of the MOEBIO dHEALTH program, which is inspired by Stanford Biodesign and Kaospilot Design and Business School from Denmark. MOWOOT was founded in 2014 and is based in Barcelona, Spain.

Quality Pharma's proprietary QS System® (“Quantum Satis”) is a powerful medical evaluation tool to accurately inform the selection of safe, quality medication-based treatment. Its unique algorithm-driven software effectively flags the potential for adverse drug events in polypharmacy, with its unparalleled ability to diagnose and reveal specific indicators (inappropriate drugs, drug duplication, drug-drug interactions, drug-disease interactions, undertreatment etc.) as well as potential adverse drug reactions in treatment programmes of multiple drugs. With modules for analysis, monitoring and evaluation, Quantum Satis traverses healthcare and brings decision support to all frontline healthcare and pharma professionals. It also provides a user-friendly interactive version for individuals, their carers and family members to complement and empower their own healthcare provision, helping ensure potential drug-related problems can be quickly identified, prevented and resolved.

NeuroHeal is a spinout from the Institut of Neurosciences from the Autonomous University of Barcelona.

ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with an easy way to detect early-stage Alzheimer.